Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising cardiovascular disease prevalence
3.2.1.2 Growing demand for extracorporeal membrane oxygenation (ECMO)
3.2.1.3 High incidence of acute respiratory distress syndrome (ARDS)
3.2.1.4 Rise in organ transplant procedures
3.2.1.5 Surging application in pediatric and neonatal care
3.2.2 Industry pitfalls and challenges
3.2.2.1 Strict regulatory requirements
3.2.2.2 High costs of advanced oxygenators
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Value chain analysis
3.11 Evolution of extracorporeal membrane oxygenators (ECMO)
3.12 AI-enabled prediction of bleeding in patients supported on ECMO
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 — 2034 ($ Mn)
5.1 Key trends
5.2 Hollow fiber membrane oxygenators
5.3 Flat sheet membrane oxygenators
Chapter 6 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)
6.1 Key trends
6.2 Respiratory
6.2.1 Respiratory failure
6.2.2 Pulmonary embolism
6.2.3 Acute respiratory distress syndrome
6.2.4 Pneumonia
6.2.5 COVID-19
6.3 Cardiac
6.3.1 Decompensated cardiomyopathy
6.3.2 Acute myocardial infarction
6.3.3 Cardiogenic shock
6.3.4 Post-transplant complications
6.3.5 Myocarditis
6.4 Extra corporeal cardiopulmonary resuscitation
Chapter 7 Market Estimates and Forecast, By Age Group, 2021 — 2034 ($ Mn)
7.1 Key trends
7.2 Adults
7.3 Neonates
7.4 Pediatrics
Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Abbott
10.2 BRAILE
10.3 chalice
10.4 CytoSorbents
10.5 EUROSETS
10.6 Fresenius
10.7 GETINGE
10.8 LivaNova
10.9 Medtronic
10.10 MicroPort
10.11 NIPRO
10.12 PrecisionMedical
10.13 RECTUS MEDICAl
10.14 TERUMO
10.15 XENIOS
